The Oncology Institute, Inc. TOI Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s net change in cash?
- The Oncology Institute, Inc. (TOI) reported net change in cash of -$3.29M in Q1 2026.
- How has The Oncology Institute, Inc.'s net change in cash changed year-over-year?
- The Oncology Institute, Inc.'s net change in cash increased by 66.9% year-over-year, from -$9.93M to -$3.29M.
- What is the long-term trend for The Oncology Institute, Inc.'s net change in cash?
- Over 2 years (2022 to 2024), The Oncology Institute, Inc.'s net change in cash has grown at a -60.0% compound annual growth rate (CAGR), from -$101.16M to $16.18M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.